Skip to main content
. Author manuscript; available in PMC: 2010 Dec 1.
Published in final edited form as: Expert Rev Ophthalmol. 2010 Feb 1;5(1):75–93. doi: 10.1586/eop.09.70

Table 2.

Limitations of topical and systemic drug administration.

Topical Systemic
Lacrimation Blood–retinal barrier
Impermeability of corneal epithelium
and endothelium
RPE efflux pumps: P-glycoprotein and
multidrug resistance-associated protein
Aqueous production Higher therapeutic index
Blood flow Increased drug accumulation throughout
other body tissues
Stromal tissues of cornea and sclera

RPE: Retinal pigment epithelium.

Data from [18].